Paper Review Records
All Paper Review Records
13 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Development and validation of a baseline interpretable prognostic model for mortality risk stratification in myelodysplastic syndrome patients receiving hypomethylating agent therapy
Yemei Jiang; Yaofeng Chen; Jiexing Guo; Siyuan Luo; Zijian Liang; Yujin Wu; Hua Yang; Yang XunShow moreShow less
The Third Affiliated Hospital, School of Medicine, Foshan University, Foshan, Guangdong Province, 528231, ChinaShow moreShow less
Pregnancy and classic Hodgkin lymphoma: real world outcomes from a single center in Egypt
Shaimaa EL-Ashwah; Salma Elashwah; Malak S. Najah; Gehad A. Saleh; Eman M Ibrahim; Yasmine ShaabanShow moreShow less
Clinical Hematology, Oncology Center, Mansoura University (OCMU), Faculty of Medicine, Mansoura University, Mansoura, Egypt; Medical Oncology, Oncology Center, Mansoura University (OCMU), Faculty of Medicine, Mansoura University, Mansoura, Egypt; Medical Student, Manchester Program, Faculty of Medicine, Mansoura University, Mansoura, Egypt; Intervention Radiology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt; Department of Anatomic Pathology, Faculty of Medicine, Mansoura University, Mansoura, EgyptShow moreShow less
Reflection of patient-reported anxiety via ePRO in routine pharmacist documentation during cancer chemotherapy: A paired analysis with sensitivity analyses
Yuki Takei; Atsufumi Nomoto; Mizuki Kawashima; Yuko Miyake; Arisa Kawakami; Tadamitsu Shima; Isao Teshima; Natsumi Nomoto; Yoshiharu Mitsunaga; Tamaki Watanabe; Yukie Nagase; Nobuhiro YasunoShow moreShow less
Department of Pharmacy, Teikyo University Hospital, 2-11-1 Kaga, Itabashi, Tokyo, 173-8606, Japan; Laboratory of Hospital Pharmacy Science, Faculty of Pharma-Science, Teikyo University, 2-11-1 Kaga, Itabashi, Tokyo, 173-8606, JapanShow moreShow less
Predictors of change in cognitive function for patients with cancer treated with allogeneic hematopoietic cell transplant
Megha Jacob; Matthew A. Bergens; Matthew Braun; Ernaya J. Johnson; Yan Li; Amy T. Bush; Lauren Hill; Sanghee Hong; Patrick Smith; Anthony D. Sung; Jamie S. MyersShow moreShow less
Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, 2650 Shawnee Mission Parkway, Westwood, KS, 66205, USA; Department of Emergency Medicine, Duke University School of Medicine, 2301 Erwin Rd, Durham, NC, 27710, USA; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, 2400 Pratt St, Durham, NC, 277705-3976, USA; Duke Cancer Institute Biostatistics Shared Resource, Duke University School of Medicine, Hock Plaza, 8th floor, 2424 Erwin Rd., Durham, NC, 27710, USA; Departments of Psychiatry and Neurology, University of North Carolina at Chapel Hill, 101 Manning Dr., Chapel Hill, NC, 27514, USA; School of Nursing, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS, 66160, USAShow moreShow less
Spatial transcriptomics of primary and metastatic ALK-rearranged NSCLC reveals site-specific adaptations
Warisa Khatoon; Kaustar Yadav; Amit Katiyar; Sunil Kumar; Sudheer Arava; Anant Mohan; Rambha Pandey; Chandrashekhara SH; Aruna Nambirajan; Prabhat Singh Malik; Deepali JainShow moreShow less
Department of Pathology, All India Institute of Medical Sciences, New Delhi, India; Centralized Core Research Facility, All India Institute of Medical Sciences, New Delhi, India; Department of Surgical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India; Department of Pulmonary, Critical Care & Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India; Department of Radiation Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India; Department of Radiodiagnosis, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India; Department of Medical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, IndiaShow moreShow less
Experience of the implementation of a lung cancer screening program at the Hospital General de Catalunya (Barcelona, Spain)
Irene Moya-Horno; Adrián González-Marrón; Paula Barcos-Muñoz; Santiago Abad; Miguel Ángel Molina-Vila; Antoni Torres-Martí; Xavier González; Núria Mayolas; Rafael RosellShow moreShow less
Medical Oncology, Hospital Universitari General de Catalunya, Instituto Oncológico Dr Rosell, Pangaea Oncology, Sant Cugat del Vallès, Spain; Department of Medicine, School of Medicine and Health Sciences, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Barcelona, Spain; Pulmonology, Hospital Universitari General de Catalunya, Instituto Oncológico Dr Rosell, Pangaea Oncology, Sant Cugat del Vallès, Spain; Laboratory, Hospital Universitari Quirón Dexeus, Instituto Oncológico Dr Rosell, Pangaea Oncology, Barcelona, Spain; Radiology, Hospital Universitari General de Catalunya, Sant Cugat del Vallès, Spain; Medical Oncology, Hospital Universitari Quirón Dexeus, Instituto Oncológico Dr Rosell, Pangaea Oncology, Barcelona, Spain; Instituto de Investigación Germans Trias i Pujol, Badalona, SpainShow moreShow less
FAQ
How long does CURRENT PROBLEMS IN CANCER take to review a manuscript?
As of 2026-11-14, CrushSCI has 13 complete review records for CURRENT PROBLEMS IN CANCER. The fastest paper went from submission to acceptance in 28 days (Genomic risk distribution, adjuvant chemotherapy trends, and survival outcomes in women with pT1, grade 1-2, ER/PR-positive, LVI-negative breast cancer, received 2026-06-03, accepted 2026-07-01); the slowest took 291 days. The average is 126.2 days and the median is 81 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
